| Bioactivity | Enfortumab is a monoclonal antibody targeting Nectin-4. Enfortumab can used for researching urothelial cancer[1]. |
| Name | Enfortumab |
| CAS | 1448664-46-7 |
| Appearance | Liquid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Rosenberg JE, et al. Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy. J Clin Oncol. 2019;37(29):2592-2600. |